Patents by Inventor ANA KARINA BRAMBILLA COSTA

ANA KARINA BRAMBILLA COSTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11578347
    Abstract: The present disclosure provides recombinant microorganisms and methods for the anaerobic production of 2,4-furandimethanol from one or more carbon sources. The microorganisms and methods provide redox-balanced and ATP positive pathways for co-producing 2,4-furandimethanol with ethanol and for co-producing 2,4-furandimethanol with ethanol and acetone and/or isopropanol. The method provides recombinant microorganisms that express endogenous and/or exogenous nucleic acid molecules encoding polypeptides that catalyze the conversion of a carbon source into 2,4-furandimethanol and that couple the 2,4-furandimethanol pathway with an additional metabolic pathway. The present disclosure further provides enzymatic production of 2,4-furandicarboxylic acid.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: February 14, 2023
    Assignee: BRASKEM S.A.
    Inventors: Iuri Estrada Gouvea, Ana Karina Brambilla Costa, Marcos Rogerio Simoes, Veronica Leite Queiroz, Aline Silva Romão Dumaresq
  • Publication number: 20220064682
    Abstract: The present disclosure provides recombinant microorganisms and methods for the anaerobic production of 2,4-furandimethanol from one or more carbon sources. The microorganisms and methods provide redox-balanced and ATP positive pathways for co-producing 2,4-furandimethanol with ethanol and for co-producing 2,4-furandimethanol with ethanol and acetone and/or isopropanol. The method provides recombinant microorganisms that express endogenous and/or exogenous nucleic acid molecules encoding polypeptides that catalyze the conversion of a carbon source into 2,4-furandimethanol and that couple the 2,4-furandimethanol pathway with an additional metabolic pathway. The present disclosure further provides enzymatic production of 2,4-furandicarboxylic acid.
    Type: Application
    Filed: September 1, 2021
    Publication date: March 3, 2022
    Inventors: Iuri Estrada GOUVEA, Ana Karina BRAMBILLA COSTA, Marcos Rogerio SIMOES, Veronica Leite QUEIROZ, Aline Silva ROMÃO DUMARESQ
  • Patent number: 11162116
    Abstract: The present disclosure relates to single and/or multi-stage, biological processes and systems for converting C5, C6, and/or disaccharide carbon sources to desirable products including monoethylene glycol (MEG) and one or more three-carbon compounds such as acetone, isopropanol or propene. The MEG and one or more three-carbon compounds described herein are useful as starting material for production of other compounds or as end products for industrial and household use. The disclosure further relates to the processes carrying out fermentations of substrates in a single phase bioreactor or in a multiphase bioreactor comprising growth and production phases. Additionally, the processes and systems described herein result in high productivity and yield of the desired products due to intermittent or continuous removal of products to avoid inhibitory effects.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: November 2, 2021
    Assignee: BRASKEM S.A.
    Inventors: Jose Geraldo Da Cruz Pradella, Ane Fernanda Beraldi Zeidler, Ana Karina Brambilla Costa
  • Publication number: 20190276858
    Abstract: The present disclosure relates to single and/or multi-stage, biological processes and systems for converting C5, C6, and/or disaccharide carbon sources to desirable products including monoethylene glycol (MEG) and one or more three-carbon compounds such as acetone, isopropanol or propene. The MEG and one or more three-carbon compounds described herein are useful as starting material for production of other compounds or as end products for industrial and household use. The disclosure further relates to the processes carrying out fermentations of substrates in a single phase bioreactor or in a multiphase bioreactor comprising growth and production phases. Additionally, the processes and systems described herein result in high productivity and yield of the desired products due to intermittent or continuous removal of products to avoid inhibitory effects.
    Type: Application
    Filed: March 12, 2019
    Publication date: September 12, 2019
    Inventors: JOSE GERALDO DA CRUZ PRADELLA, ANE FERNANDA BERALDI ZEIDLER, ANA KARINA BRAMBILLA COSTA